SynthesisPloS one2012

Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.

Ping Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.